查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1941819

美国耐用医疗设备市场规模、份额和趋势分析报告：按产品、最终用途和细分市场预测（2026-2033 年）

U.S. Durable Medical Equipment Market Size, Share & Trends Analysis Report By Product, By End Use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 300 Pages | 商品交期: 2-10个工作天内

价格

美国耐用医疗设备市场概述

据估计，2025年美国耐用医疗设备市场价值为706.6亿美元，预计到2033年将达到1,087.3亿美元。

预计2026年至2033年，该市场将以5.51%的复合年增长率成长。癌症、神经系统疾病、糖尿病和心臟病等慢性疾病的发生率逐年上升。根据美国疾病管制与预防中心（CDC）2024年5月发布的数据，糖尿病、心臟病和癌症等慢性疾病是美国残疾和致死的主要原因。患有癌症等慢性疾病的患者人数不断增加，而且由于慢性疾病患者可能存在行动不便的问题，因此对耐用医疗设备的需求预计将会增长。

根据Lifeway Mobility于2023年9月发表的报导，约有25%至35%的癌症患者会出现行走困难、平衡失调和四肢麻木等问题。因此，随着癌症发生率的上升，美国对助行器、轮椅和其他行动辅助设备等耐用型医疗设备的需求预计将会成长。

目录

第一章：调查方法和范围

第二章执行摘要

第三章：耐用医疗设备市场的变数、趋势与范围

  • 市场谱系展望
    • 相关市场展望
  • 监管情景
  • 救赎方案
  • 市场动态
  • 耐用医疗设备市场分析工具
    • 产业分析：波特五力模型
    • PESTEL 分析
    • 新冠疫情影响分析

第四章：耐用医疗设备市场：产品具体估算与趋势分析

  • 耐用医疗设备市场：产品波动分析及市场份额（2025 年及 2033 年）
  • 个人行动装置
    • 轮椅市场
    • Scooter市场
    • 沃克和罗勒市场
    • 起重机和拐杖市场
    • 开门器市场
    • 其他设备市场
  • 浴室安全装置和医疗家具
    • 厕所和厕所市场
    • 床垫和寝具市场
  • 行政和治疗设备
    • 血糖值仪市场
    • 持续被动运动（CPM）市场
    • 输液帮浦市场
    • 雾化器市场
    • 输液帮浦市场
    • 氧气供应设备市场
    • 持续性阳压呼吸器（CPAP）市场
    • 吸泵市场
    • 牵引设备市场
    • 其他市场

第五章：耐用医疗设备市场：依最终用途分類的估算与趋势分析

  • 耐用医疗设备市场：波动分析及依最终用途分類的市场份额（2025 年及 2033 年）
  • 医院
  • 专科诊所
  • 门诊手术中心
  • 诊断中心
  • 居家医疗
  • 其他的

第六章 竞争情势

  • 参与企业的分类
  • 主要企业简介
    • Invacare Corporation
    • Sunrise Medical
    • Arjo
    • Medline Industries, Inc.
    • GE HealthCare
    • GF Healthcare Products, Inc.
    • Carex Health Brands, Inc.
    • Cardinal Health
    • Drive DeVilbiss Healthcare
    • NOVA Medical Products
    • Kaye Products, Inc.
    • Karman Healthcare, Inc.
    • Numotion
    • Pride Mobility Products Corporation
    • Inogen, Inc.
    • CAIRE, Inc.
    • Portable Oxygen Solutions
    • Rhythm Healthcare, LLC
    • MedaCure Inc.
    • Compass Health Brands
    • Thermo Fisher Scientific, Inc.
    • Abbott
    • F. Hoffmann-La Roche Ltd.
    • Medtronic
    • Ascensia Diabetes Care Holdings AG
    • Byram Healthcare Centers, Inc.
    • Novo Nordisk
    • Insulet Corporation
    • Baxter
    • B. Braun SE
    • Micrel Medical Devices SA
    • Boston Scientific Corporation
    • Tandem Diabetes Care, Inc.
    • BD
    • Moog, Inc.
    • IRadimed Corporation
    • Koninklijke Philips NV
    • Siemens Medical Solutions USA, Inc.
    • Essity
    • Coloplast Corporation
    • Paul Hartmann AG
    • Hollister Incorporated
    • Convatec Group PLC
    • Enovis Corporation
    • Zynex, Inc.
    • ZOLL Medical Corporation
    • Ossur
    • Breg, Inc.
    • Bauerfeind USA, Inc.
    • Biotronik
    • AliMed
  • 地图分析/企业市场分析
  • 企业市场占有率预测分析（2025 年）
  • 其他主要市场参与者名单
Product Code: GVR-1-68038-926-5

U.S. Durable Medical Equipment Market Summary

The U.S. durable medical equipmentmarket size was estimated at USD 70.66 billion in 2025 and is projected to reach USD 108.73 billion by 2033, growing at a CAGR of 5.51% from 2026 to 2033. The prevalence of chronic diseases, such as cancer, neurological conditions, diabetes, and heart disorders, is increasing annually. According to the data published by the CDC in May 2024, chronic diseases such as diabetes, heart disease, & cancer are the leading causes of disability and death in the U.S. The increasing number of individuals suffering from chronic diseases such as cancer is anticipated to boost the demand for durable medical equipment as patients suffering from chronic conditions can experience mobility issues.

According to an article published by Lifeway Mobility in September 2023, around 25%-35% of cancer patients experience issues with walking, balance, and limb numbness. Hence, the growing cancer prevalence is anticipated to boost the demand for durable medical equipment, such as walkers, wheelchairs, and other mobility solutions in the U.S.

U.S. Durable Medical Equipment Market Report Segmentation

This report forecasts revenue growth at the country level and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. durable medical equipment market report based on product, and end use.

  • Product Outlook (Revenue, USD Million, 2021 - 2033)
  • Personal Mobility Devices
    • Wheelchairs
    • Electric Wheelchairs
    • Manual Wheelchairs
    • Scooters
    • Walker and Rollators
    • Cranes and Crutches
    • Door Openers
    • Other Devices
  • Bathroom Safety Devices and Medical Furniture
    • Commodes and Toilets
    • Mattress & Bedding Devices
  • Monitoring and Therapeutic Devices
    • Blood Glucose Monitors
    • Continuous Passive Motion (CPM)
    • Infusion Pumps
    • Nebulizers
    • Oxygen equipment
    • Continuous Positive Airway Pressure (CPAP)
    • Suction Pumps
    • Traction Equipment
    • Others
    • Insulin Pumps
    • Ostomy Bags & Accessories
    • Wound Care Products
    • Cardiology Devices
    • Vital Signs Monitor
    • Respiratory Supplies
    • Urinary Supplies
    • Diabetic Supplies
    • Incontinence Products
    • Orthopedic Braces & Support
    • Muscle Stimulators
    • Others
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Specialty Clinics
  • Ambulatory Surgical Centers
  • Diagnostic Centers
  • Home Healthcare
  • Others

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Research Methodology
  • 1.3. Information Procurement
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. DME Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Ancillary Market Outlook
  • 3.2. Regulatory Scenario
  • 3.3. Reimbursement Scenario
  • 3.4. Market Dynamics
    • 3.4.1. Market Driver Analysis
      • 3.4.1.1. Increasing prevalence of chronic diseases
      • 3.4.1.2. Rising geriatric population
      • 3.4.1.3. Technological advancements and growing AI integration
      • 3.4.1.4. Growing number of sports & road accidents coupled with the increasing number of injuries
      • 3.4.1.5. Favorable government initiatives
    • 3.4.2. Market Restraint Analysis
      • 3.4.2.1. High costs associated with durable medical equipment
      • 3.4.2.2. Lack of skilled professionals to handle this equipment
    • 3.4.3. Market Opportunity Analysis
      • 3.4.3.1. Growing demand for home healthcare services
      • 3.4.3.2. Improving reimbursement for durable medical equipment
      • 3.4.3.3. Rising production of medical equipment
      • 3.4.3.4. Growing accessibility and availability of medical equipment
      • 3.4.3.5. Increasing investments in medical
    • 3.4.4. Market Challenge Analysis
      • 3.4.4.1. Product recall
      • 3.4.4.2. Growing accessibility and availability of medical equipment
  • 3.5. DME Market Analysis Tools
    • 3.5.1. Industry Analysis - Porter's
      • 3.5.1.1. Bargaining power of suppliers
      • 3.5.1.2. Bargaining power of buyers
      • 3.5.1.3. Threat of substitutes
      • 3.5.1.4. Threat of new entrants
      • 3.5.1.5. Competitive rivalry
    • 3.5.2. PESTEL Analysis
      • 3.5.2.1. Political & Legal Landscape
      • 3.5.2.2. Economic and Social Landscape
      • 3.5.2.3. Technological landscape
    • 3.5.3. COVID-19 Impact Analysis
      • 3.5.3.1. Disrupted DME
      • 3.5.3.2. Obstacles in DME

Chapter 4. DME Market: Product Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. DME Market: Product Movement Analysis & Market Share, 2025 & 2033
  • 4.3. Personal Mobility Devices
    • 4.3.1. Personal Mobility Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.2. Wheelchairs Market
      • 4.3.2.1 Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.2 Electric Wheelchairs Market
        • 4.3.2.2.1 Electric Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.3.2.3 Manual Wheelchairs Market
        • 4.3.2.3.1 Manual Wheelchairs Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.3. Scooters Market
      • 4.3.3.1 Scooters Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.4. Walker and Rollators Market
      • 4.3.4.1 Walker and Rollators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.5. Cranes and Crutches Market
      • 4.3.5.1 Cranes and Crutches Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.6. Door Openers Market
      • 4.3.6.1 Door Openers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.3.7. Other Devices Market
      • 4.3.7.1 Other Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.4. Bathroom Safety Devices and Medical Furniture
    • 4.4.1. Bathroom Safety Devices and Medical Furniture Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.2. Commodes and Toilets Market
      • 4.4.2.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.4.3. Mattress & Bedding Devices Market
      • 4.4.3.1 Mattress & Bedding Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Monitoring and Therapeutic Devices
    • 4.5.1. Monitoring and Therapeutic Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.2. Blood Sugar Monitors Market
      • 4.5.2.1 Blood Sugar Monitors Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.3. Continuous Passive Motion (CPM) Market
      • 4.5.3.1 Commodes and Toilets Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.4. Infusion Pumps Market
      • 4.5.4.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.5. Nebulizers Market
      • 4.5.5.1 Nebulizers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.6. Infusion Pumps Market
      • 4.5.6.1 Infusion Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.7. Oxygen Equipment Market
      • 4.5.7.1 Oxygen Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.8. Continuous Positive Airway Pressure (CPAP) Market
      • 4.5.8.1 Continuous Positive Airway Pressure (CPAP) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.9. Suction pumps Market
      • 4.5.9.1 Suction Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.10. Traction equipment Market
      • 4.5.10.1 Traction Equipment Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.11. Others Market
      • 4.5.11.1 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.2 Insulin Pumps Market
        • 4.5.11.2.1 Insulin Pumps Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.3 Ostomy Bags & Accessories Market
        • 4.5.11.3.1 Ostomy Bags & Accessories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.4 Wound Care Products Market
        • 4.5.11.4.1 Wound Care Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.5 Cardiology Devices Market
        • 4.5.11.5.1 Cardiology Devices Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.6 Vital Signs Monitor Market
        • 4.5.11.6.1 Vital Signs Monitor Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.7 Respiratory Supplies Market
        • 4.5.11.7.1 Respiratory Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.8 Urinary Supplies Market
        • 4.5.11.8.1 Urinary Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.9 Diabetic Supplies Market
        • 4.5.11.9.1 Diabetic Supplies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.10 Incontinence Products Market
        • 4.5.11.10.1 Incontinence Products Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.11 Orthopedic Braces & Support Market
        • 4.5.11.11.1 Orthopedic Braces & Support Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.12 Muscle Stimulators Market
        • 4.5.11.12.1 Muscle Stimulators Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
      • 4.5.11.13 Others Market
        • 4.5.11.13.1 Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. DME Market: End Use Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. DME Market: End Use Movement Analysis & Market Share, 2025 & 2033
  • 5.3. Hospitals
    • 5.3.1. Hospitals Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.4. Specialty Clinics
    • 5.4.1. Specialty Clinics Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. Ambulatory Surgical Centers
    • 5.5.1. Ambulatory Surgical Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.6. Diagnostic Centers
    • 5.6.1. Diagnostic Centers Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.7. Home Healthcare
    • 5.7.1. Home Healthcare Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.8. Others
    • 5.8.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Competitive Landscape

  • 6.1. Market Participant Categorization
  • 6.2. Key Company Profiles
    • 6.2.1. Invacare Corporation
      • 6.2.1.1. Company Overview
      • 6.2.1.2. Financial Performance
      • 6.2.1.3. Product Benchmarking
      • 6.2.1.4. Strategic Initiatives
    • 6.2.2. Sunrise Medical
      • 6.2.2.1. Company Overview
      • 6.2.2.2. Financial Performance
      • 6.2.2.3. Product Benchmarking
      • 6.2.2.4. Strategic Initiatives
    • 6.2.3. Arjo
      • 6.2.3.1. Company Overview
      • 6.2.3.2. Financial Performance
      • 6.2.3.3. Product Benchmarking
      • 6.2.3.4. Strategic Initiatives
    • 6.2.4. Medline Industries, Inc.
      • 6.2.4.1. Company Overview
      • 6.2.4.2. Financial Performance
      • 6.2.4.3. Product Benchmarking
      • 6.2.4.4. Strategic Initiatives
    • 6.2.5. GE HealthCare
      • 6.2.5.1. Company Overview
      • 6.2.5.2. Financial Performance
      • 6.2.5.3. Product Benchmarking
      • 6.2.5.4. Strategic Initiatives
    • 6.2.6. GF Healthcare Products, Inc.
      • 6.2.6.1. Company Overview
      • 6.2.6.2. Financial Performance
      • 6.2.6.3. Product Benchmarking
      • 6.2.6.4. Strategic Initiatives
    • 6.2.7. Carex Health Brands, Inc.
      • 6.2.7.1. Company Overview
      • 6.2.7.2. Financial Performance
      • 6.2.7.3. Product Benchmarking
      • 6.2.7.4. Strategic Initiatives
    • 6.2.8. Cardinal Health
      • 6.2.8.1. Company Overview
      • 6.2.8.2. Financial Performance
      • 6.2.8.3. Product Benchmarking
      • 6.2.8.4. Strategic Initiatives
    • 6.2.9. Drive DeVilbiss Healthcare
      • 6.2.9.1. Company Overview
      • 6.2.9.2. Financial Performance
      • 6.2.9.3. Product Benchmarking
      • 6.2.9.4. Strategic Initiatives
    • 6.2.10. NOVA Medical Products
      • 6.2.10.1. Company Overview
      • 6.2.10.2. Financial Performance
      • 6.2.10.3. Product Benchmarking
      • 6.2.10.4. Strategic Initiatives
    • 6.2.11. Kaye Products, Inc.
      • 6.2.11.1. Company Overview
      • 6.2.11.2. Financial Performance
      • 6.2.11.3. Product Benchmarking
      • 6.2.11.4. Strategic Initiatives
    • 6.2.12. Karman Healthcare, Inc.
      • 6.2.12.1. Company Overview
      • 6.2.12.2. Financial Performance
      • 6.2.12.3. Product Benchmarking
      • 6.2.12.4. Strategic Initiatives
    • 6.2.13. Numotion
      • 6.2.13.1. Company Overview
      • 6.2.13.2. Financial Performance
      • 6.2.13.3. Product Benchmarking
      • 6.2.13.4. Strategic Initiatives
    • 6.2.14. Pride Mobility Products Corporation
      • 6.2.14.1. Company Overview
      • 6.2.14.2. Financial Performance
      • 6.2.14.3. Product Benchmarking
      • 6.2.14.4. Strategic Initiatives
    • 6.2.15. Inogen, Inc.
      • 6.2.15.1. Company Overview
      • 6.2.15.2. Financial Performance
      • 6.2.15.3. Product Benchmarking
      • 6.2.15.4. Strategic Initiatives
    • 6.2.16. CAIRE, Inc.
      • 6.2.16.1. Company Overview
      • 6.2.16.2. Financial Performance
      • 6.2.16.3. Product Benchmarking
      • 6.2.16.4. Strategic Initiatives
    • 6.2.17. Portable Oxygen Solutions
      • 6.2.17.1. Company Overview
      • 6.2.17.2. Financial Performance
      • 6.2.17.3. Product Benchmarking
      • 6.2.17.4. Strategic Initiatives
    • 6.2.18. Rhythm Healthcare, LLC
      • 6.2.18.1. Company Overview
      • 6.2.18.2. Financial Performance
      • 6.2.18.3. Product Benchmarking
      • 6.2.18.4. Strategic Initiatives
    • 6.2.19. MedaCure Inc.
      • 6.2.19.1. Company Overview
      • 6.2.19.2. Financial Performance
      • 6.2.19.3. Product Benchmarking
      • 6.2.19.4. Strategic Initiatives
    • 6.2.20. Compass Health Brands
      • 6.2.20.1. Company Overview
      • 6.2.20.2. Financial Performance
      • 6.2.20.3. Product Benchmarking
      • 6.2.20.4. Strategic Initiatives
    • 6.2.21. Thermo Fisher Scientific, Inc.
      • 6.2.21.1. Company Overview
      • 6.2.21.2. Financial Performance
      • 6.2.21.3. Product Benchmarking
      • 6.2.21.4. Strategic Initiatives
    • 6.2.22. Abbott
      • 6.2.22.1. Company Overview
      • 6.2.22.2. Financial Performance
      • 6.2.22.3. Product Benchmarking
      • 6.2.22.4. Strategic Initiatives
    • 6.2.23. F. Hoffmann-La Roche Ltd.
      • 6.2.23.1. Company Overview
      • 6.2.23.2. Financial Performance
      • 6.2.23.3. Product Benchmarking
      • 6.2.23.4. Strategic Initiatives
    • 6.2.24. Medtronic
      • 6.2.24.1. Company Overview
      • 6.2.24.2. Financial Performance
      • 6.2.24.3. Product Benchmarking
      • 6.2.24.4. Strategic Initiatives
    • 6.2.25. Ascensia Diabetes Care Holdings AG
      • 6.2.25.1. Company Overview
      • 6.2.25.2. Financial Performance
      • 6.2.25.3. Product Benchmarking
      • 6.2.25.4. Strategic Initiatives
    • 6.2.26. Byram Healthcare Centers, Inc.
      • 6.2.26.1. Company Overview
      • 6.2.26.2. Financial Performance
      • 6.2.26.3. Product Benchmarking
      • 6.2.26.4. Strategic Initiatives
    • 6.2.27. Novo Nordisk
      • 6.2.27.1. Company Overview
      • 6.2.27.2. Financial Performance
      • 6.2.27.3. Product Benchmarking
      • 6.2.27.4. Strategic Initiatives
    • 6.2.28. Insulet Corporation
      • 6.2.28.1. Company Overview
      • 6.2.28.2. Financial Performance
      • 6.2.28.3. Product Benchmarking
      • 6.2.28.4. Strategic Initiatives
    • 6.2.29. Baxter
      • 6.2.29.1. Company Overview
      • 6.2.29.2. Financial Performance
      • 6.2.29.3. Product Benchmarking
      • 6.2.29.4. Strategic Initiatives
    • 6.2.30. B. Braun SE
      • 6.2.30.1. Company Overview
      • 6.2.30.2. Financial Performance
      • 6.2.30.3. Product Benchmarking
      • 6.2.30.4. Strategic Initiatives
    • 6.2.31. Micrel Medical Devices SA
      • 6.2.31.1. Company Overview
      • 6.2.31.2. Financial Performance
      • 6.2.31.3. Product Benchmarking
      • 6.2.31.4. Strategic Initiatives
    • 6.2.32. Boston Scientific Corporation
      • 6.2.32.1. Company Overview
      • 6.2.32.2. Financial Performance
      • 6.2.32.3. Product Benchmarking
      • 6.2.32.4. Strategic Initiatives
    • 6.2.33. Tandem Diabetes Care, Inc.
      • 6.2.33.1. Company Overview
      • 6.2.33.2. Financial Performance
      • 6.2.33.3. Product Benchmarking
      • 6.2.33.4. Strategic Initiatives
    • 6.2.34. BD
      • 6.2.34.1. Company Overview
      • 6.2.34.2. Financial Performance
      • 6.2.34.3. Product Benchmarking
      • 6.2.34.4. Strategic Initiatives
    • 6.2.35. Moog, Inc.
      • 6.2.35.1. Company Overview
      • 6.2.35.2. Financial Performance
      • 6.2.35.3. Product Benchmarking
      • 6.2.35.4. Strategic Initiatives
    • 6.2.36. IRadimed Corporation
      • 6.2.36.1. Company Overview
      • 6.2.36.2. Financial Performance
      • 6.2.36.3. Product Benchmarking
      • 6.2.36.4. Strategic Initiatives
    • 6.2.37. Koninklijke Philips N.V.
      • 6.2.37.1. Company Overview
      • 6.2.37.2. Financial Performance
      • 6.2.37.3. Product Benchmarking
      • 6.2.37.4. Strategic Initiatives
    • 6.2.38. Siemens Medical Solutions USA, Inc.
      • 6.2.38.1. Company Overview
      • 6.2.38.2. Financial Performance
      • 6.2.38.3. Product Benchmarking
      • 6.2.38.4. Strategic Initiatives
    • 6.2.39. Essity
      • 6.2.39.1. Company Overview
      • 6.2.39.2. Financial Performance
      • 6.2.39.3. Product Benchmarking
      • 6.2.39.4. Strategic Initiatives
    • 6.2.40. Coloplast Corporation
      • 6.2.40.1. Company Overview
      • 6.2.40.2. Financial Performance
      • 6.2.40.3. Product Benchmarking
      • 6.2.40.4. Strategic Initiatives
    • 6.2.41. Paul Hartmann AG
      • 6.2.41.1. Company Overview
      • 6.2.41.2. Financial Performance
      • 6.2.41.3. Product Benchmarking
      • 6.2.41.4. Strategic Initiatives
    • 6.2.42. Hollister Incorporated
      • 6.2.42.1. Company Overview
      • 6.2.42.2. Financial Performance
      • 6.2.42.3. Product Benchmarking
      • 6.2.42.4. Strategic Initiatives
    • 6.2.43. Convatec Group PLC
      • 6.2.43.1. Company Overview
      • 6.2.43.2. Financial Performance
      • 6.2.43.3. Product Benchmarking
      • 6.2.43.4. Strategic Initiatives
    • 6.2.44. Enovis Corporation
      • 6.2.44.1. Company Overview
      • 6.2.44.2. Financial Performance
      • 6.2.44.3. Product Benchmarking
      • 6.2.44.4. Strategic Initiatives
    • 6.2.45. Zynex, Inc.
      • 6.2.45.1. Company Overview
      • 6.2.45.2. Financial Performance
      • 6.2.45.3. Product Benchmarking
      • 6.2.45.4. Strategic Initiatives
    • 6.2.46. ZOLL Medical Corporation
      • 6.2.46.1. Company Overview
      • 6.2.46.2. Financial Performance
      • 6.2.46.3. Product Benchmarking
      • 6.2.46.4. Strategic Initiatives
    • 6.2.47. Ossur
      • 6.2.47.1. Company Overview
      • 6.2.47.2. Financial Performance
      • 6.2.47.3. Product Benchmarking
      • 6.2.47.4. Strategic Initiatives
    • 6.2.48. Breg, Inc.
      • 6.2.48.1. Company Overview
      • 6.2.48.2. Financial Performance
      • 6.2.48.3. Product Benchmarking
      • 6.2.48.4. Strategic Initiatives
    • 6.2.49. Bauerfeind USA, Inc.
      • 6.2.49.1. Company Overview
      • 6.2.49.2. Financial Performance
      • 6.2.49.3. Product Benchmarking
      • 6.2.49.4. Strategic Initiatives
    • 6.2.50. Biotronik
      • 6.2.50.1. Company Overview
      • 6.2.50.2. Financial Performance
      • 6.2.50.3. Product Benchmarking
      • 6.2.50.4. Strategic Initiatives
    • 6.2.51. AliMed
      • 6.2.51.1. Heat Company Overview
      • 6.2.51.2. Financial Performance
      • 6.2.51.3. Product Benchmarking
      • 6.2.51.4. Strategic Initiatives
  • 6.3. Map Analysis/ Company Market Position Analysis
  • 6.4. Estimated Company Market Share Analysis, 2025
  • 6.5. List of Other Key Market Players

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 US DME Market, by Product, 2021 - 2033 (USD Million)
  • Table 4 US DME Market, by End Use, 2021 - 2033 (USD Million)
  • Table 5 Participant's Overview
  • Table 6 Financial Performance
  • Table 7 Service Benchmarking
  • Table 8 Strategic Initiatives

List of Figures

  • Fig. 1 Information Procurement
  • Fig. 2 Primary Research Pattern
  • Fig. 3 Market Research Approaches
  • Fig. 4 Value Chain-Based Sizing & Forecasting
  • Fig. 5 Market Formulation & Validation
  • Fig. 6 DME Market, Market Segmentation
  • Fig. 7 Market Driver Relevance Analysis (Current & Future Impact)
  • Fig. 8 Market Restraint Relevance Analysis (Current & Future Impact)
  • Fig. 9 Market Challenge Relevance Analysis (Current & Future Impact)
  • Fig. 10 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
  • Fig. 11 Porter's Five Forces Analysis
  • Fig. 12 Country Marketplace: Key Takeaways
  • Fig. 13 U.S. DME Market, 2021 - 2033 (USD Million)